A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors

by Sebastian Otto-Meyer, Rian DeFaccio, Corey Dussold, Erik Ladomersky, Lijie Zhai, Kristen L. Lauing, Lakshmi R. Bollu, Christina Amidei, Rimas V. Lukas, Denise M. Scholtens, Derek A. Wainwright
Published 2020-02-01

Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)

by Lijie Zhai, Erik Ladomersky, Kristen L. Lauing, Meijing Wu, Denise M. Scholtens, Rohan Savoor, Bin Zhang, Jennifer D. Wu, Craig Horbinski, Rimas V. Lukas, David C. Binder, Derek A. Wainwright
Published 2019-03-01

The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma

by Erik Ladomersky, Denise M. Scholtens, Denise M. Scholtens, Masha Kocherginsky, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Jennifer D. Wu, Bin Zhang, Bin Zhang, Rimas V. Lukas, Rimas V. Lukas, Derek A. Wainwright, Derek A. Wainwright, Derek A. Wainwright, Derek A. Wainwright
Published 2019-03-01

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

by Lijie Zhai, April Bell, Erik Ladomersky, Kristen L. Lauing, Lakshmi Bollu, Jeffrey A. Sosman, Jeffrey A. Sosman, Bin Zhang, Bin Zhang, Bin Zhang, Jennifer D. Wu, Jennifer D. Wu, Jennifer D. Wu, Stephen D. Miller, Stephen D. Miller, Joshua J. Meeks, Joshua J. Meeks, Joshua J. Meeks, Rimas V. Lukas, Rimas V. Lukas, Eugene Wyatt, Eugene Wyatt, Lynn Doglio, Lynn Doglio, Gary E. Schiltz, Gary E. Schiltz, Gary E. Schiltz, Robert H. McCusker, Derek A. Wainwright, Derek A. Wainwright, Derek A. Wainwright, Derek A. Wainwright
Published 2020-06-01